BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2026 Earnings Call Transcript May 4, 2026
BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $0.54 EPS, expectations were $0.94.
Operator: Good afternoon and welcome everyone to the BioMarin Pharmaceutical Inc. First Quarter 2026 Conference Call. Today’s conference is being recorded. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question and answer...
